drugset / Trial / NCT02596243
Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Plasmid DNA Therapeutic Vaccine(GX-188E)
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to access the efficacy and safety of GX-188E according the protocol in patients with Cervical Intraepithelial Neoplasia 2, 2/3 or 3 (CIN3)
Timeline
- Start
- 2015-08
- Primary completion
- 2018-03
- Completion
- 2018-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GX-188E | Vaccine | 1 mg | Intramuscular |